Literature DB >> 5507693

Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate.

A Guidotti, P L Ballotti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5507693     DOI: 10.1016/0006-2952(70)90251-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  The hippocampus participates in a pharmacological rat model of absence seizures.

Authors:  Justin Arcaro; Jingyi Ma; Liangwei Chu; MinChing Kuo; Seyed M Mirsattari; L Stan Leung
Journal:  Epilepsy Res       Date:  2015-12-24       Impact factor: 3.045

2.  Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.

Authors:  O Giorgi; M C Rubio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

Review 3.  Behavioral analyses of GHB: receptor mechanisms.

Authors:  Lawrence P Carter; Wouter Koek; Charles P France
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

4.  Effect of -hydroxybutyrate on the release of monoamines from the rat striatum.

Authors:  G Bustos; R H Roth
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

5.  The stimulus properties of gamma-hydroxybutyrate.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.

Authors:  A K Goodwin; P R Brown; E E W Jansen; C Jakobs; K M Gibson; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2009-02-06       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.